Arabela Cuirolo1, Konrad Plata, Adriana E Rosato. 1. Department of Internal Medicine, Division of Infectious Diseases, Virginia Commonwealth University, Richmond, VA 23298, USA.
Abstract
OBJECTIVES: One of the main characteristics of methicillin-resistant Staphylococcus aureus (MRSA) from both hospitals and community is their heterogeneous expression of resistance. Recently, we reported new heterogeneous MRSA isolates phenotypically susceptible to oxacillin despite being mecA positive. These low-level mecA-mediated resistance MRSA strains are very heterogeneous in expression (HeR) and are likely to be clinically relevant since exposure of such isolates to beta-lactams can result in high-level homotypic resistance (HoR). We hypothesized that HeR to HoR selection in these clinically relevant strains may be determined by the pre-existence of a hypermutable population that favours its selection in the presence of oxacillin. METHODS: Using established procedures, SA13011 HeR to HoR selection was performed by using subinhibitory concentrations of oxacillin and examined for mutability. Real-time RT-PCR and transcriptional profiling by DNA microarray were used to compare gene expression between both populations and related genetically modified SA13011 strain. RESULTS: We found that HeR/HoR selection by oxacillin was associated with increased mutation rate and oxacillin-mediated SOS response. We determined increased expression of both mecA and SOS response lexA/recA regulators. Mutational inactivation of lexA repressor resulted in a significant decrease in both mutation rate and oxacillin resistance in the HoR cells. Complementation of the lexA mutant strain restored oxacillin resistance to the high levels observed in the corresponding HoR wild-type strain. CONCLUSIONS: The present results support the notion that SOS response is mechanistically involved in generating mutations that, in addition to mecA induction, allow the selection of a highly oxacillin-resistant population.
OBJECTIVES: One of the main characteristics of methicillin-resistant Staphylococcus aureus (MRSA) from both hospitals and community is their heterogeneous expression of resistance. Recently, we reported new heterogeneous MRSA isolates phenotypically susceptible to oxacillin despite being mecA positive. These low-level mecA-mediated resistance MRSA strains are very heterogeneous in expression (HeR) and are likely to be clinically relevant since exposure of such isolates to beta-lactams can result in high-level homotypic resistance (HoR). We hypothesized that HeR to HoR selection in these clinically relevant strains may be determined by the pre-existence of a hypermutable population that favours its selection in the presence of oxacillin. METHODS: Using established procedures, SA13011 HeR to HoR selection was performed by using subinhibitory concentrations of oxacillin and examined for mutability. Real-time RT-PCR and transcriptional profiling by DNA microarray were used to compare gene expression between both populations and related genetically modified SA13011 strain. RESULTS: We found that HeR/HoR selection by oxacillin was associated with increased mutation rate and oxacillin-mediated SOS response. We determined increased expression of both mecA and SOS response lexA/recA regulators. Mutational inactivation of lexA repressor resulted in a significant decrease in both mutation rate and oxacillin resistance in the HoR cells. Complementation of the lexA mutant strain restored oxacillin resistance to the high levels observed in the corresponding HoR wild-type strain. CONCLUSIONS: The present results support the notion that SOS response is mechanistically involved in generating mutations that, in addition to mecA induction, allow the selection of a highly oxacillin-resistant population.
Authors: Yolanda Palom; Gopinatha Suresh Kumar; Li-Qian Tang; Manuel M Paz; Steven M Musser; Sara Rockwell; Maria Tomasz Journal: Chem Res Toxicol Date: 2002-11 Impact factor: 3.739
Authors: B C Herold; L C Immergluck; M C Maranan; D S Lauderdale; R E Gaskin; S Boyle-Vavra; C D Leitch; R S Daum Journal: JAMA Date: 1998-02-25 Impact factor: 56.272
Authors: A R Fernández De Henestrosa; T Ogi; S Aoyagi; D Chafin; J J Hayes; H Ohmori; R Woodgate Journal: Mol Microbiol Date: 2000-03 Impact factor: 3.501
Authors: Adriana E Rosato; Barry N Kreiswirth; William A Craig; William Eisner; Michael W Climo; Gordon L Archer Journal: Antimicrob Agents Chemother Date: 2003-04 Impact factor: 5.191
Authors: Shrenik Mehta; Arabela X Cuirolo; Konrad B Plata; Sarah Riosa; Jared A Silverman; Aileen Rubio; Roberto R Rosato; Adriana E Rosato Journal: Antimicrob Agents Chemother Date: 2011-10-10 Impact factor: 5.191
Authors: Zain Baaity; Friederike D von Loewenich; Elisabeth Nagy; László Orosz; Katalin Burián; Ferenc Somogyvári; József Sóki Journal: Antibiotics (Basel) Date: 2022-04-27
Authors: Shrenik Mehta; Christopher Singh; Konrad B Plata; Palas K Chanda; Arundhati Paul; Sarah Riosa; Roberto R Rosato; Adriana E Rosato Journal: Antimicrob Agents Chemother Date: 2012-09-17 Impact factor: 5.191
Authors: Clarissa Pozzi; Elaine M Waters; Justine K Rudkin; Carolyn R Schaeffer; Amanda J Lohan; Pin Tong; Brendan J Loftus; Gerald B Pier; Paul D Fey; Ruth C Massey; James P O'Gara Journal: PLoS Pathog Date: 2012-04-05 Impact factor: 6.823